Mingxing Xu

947 citations
27 papers · 733 indexed · h-index 12
Topics
Hepatocellular Carcinoma Treatment and Prognosis (4 papers)Liver physiology and pathology (4 papers)Cancer, Lipids, and Metabolism (4 papers)
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Mingxing Xu

27 papers receiving 728 citations

Peers

Mingxing Xu
Comparison fields: 5 of 88
  • Plant Science 290
  • Molecular Biology 281
  • Cancer Research 155
  • Epidemiology 72
  • Hepatology 63
Replace Rachel M. Patterson with:
Rachel M. Patterson United States
Yi‐Huan Xu China
Yun Tian China
Hanmin Li China
Anke Haugg Germany
Neville N.C. Tam United States
Kiflu Berhane United States
Tingfen Zhang China
Mingxing Xu relative to Rachel M. Patterson United States Rachel M. Patterson's profile →
Citations per field
00.5×10×20×26.3×
Rachel M. Patterson · 1×
Citations per year

Countries citing papers authored by Mingxing Xu

Since Specialization
Citations

This map shows the geographic impact of Mingxing Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxing Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxing Xu more than expected).

Fields of papers citing papers by Mingxing Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxing Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxing Xu. The network helps show where Mingxing Xu may publish in the future.

Co-authorship network of co-authors of Mingxing Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxing Xu. A scholar is included among the top collaborators of Mingxing Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxing Xu. Mingxing Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 13
4 2
5 11
6 8
7 13
8 11
9 97
10 50
11 9
12 13
13 34
14 14
15 37
16 215
17 120
18
Effects of Ivermectin on Male Rats Procreation
1
19
The serological survy of Toxoplasma infection in Wuhan city
2
20 8

About Mingxing Xu

Mingxing Xu is a scholar working on Hepatology, Cancer Research and Parasitology, having authored 27 papers that have together received 733 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Liver physiology and pathology (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (155 citations), Endocrine and Autonomic Systems (58 citations) and Hepatology (63 citations). Mingxing Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Nan Lin, Golam Jalal Ahammed, Md. Kamrul Hasan, Jingquan Yu, Xiaojian Xia, Jie Zhou, Ruiyun Xu, Zhicheng Yao, Kai Shi and Mengqi Li. Their work appears in journals such as Chemosphere, Environmental Research and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026